NEW YORK (Reuters Health) – In chronic obstructive pulmonary disease (COPD), vertebral deformities often contribute to excess height loss with aging – which in turn may lead to…
NEW YORK (Reuters Health) – A substantial proportion of women with cervical cancer who receive curative-intent radiotherapy will soon develop pelvic fractures, clinicians from the University of Texas…
NEW YORK (Reuters Health) – The bone anabolic drug teriparatide is more effective than alendronate at increasing bone mineral density (BMD) and preventing vertebral fractures in patients with…
NEW YORK (Reuters Health) – For hypothyroid patients taking levothyroxine, therapeutic levels are best maintained by taking the medication in a fasting state, at least an hour before…
NEW YORK (Reuters Health) – In postmenopausal women with osteopenia, zoledronic acid, given either once-yearly or as a single infusion, is well tolerated and effective in preventing bone…
Chad Deal, MD, Rheumatologist, Head, Center for Osteoporosis and Metabolic Bone Disease, Cleveland Clinic, discusses anabolic agents that build bone, the current parathyroid hormone drugs and the future…
Chad Deal, MD, Rheumatologist, Head, Center for Osteoporosis and Metabolic Bone Disease, Cleveland Clinic, discusses denosumab, a new treatment for osteoporosis now being used to treat patients who…
Dr. Lubna Pal, MD, is a Director of the Reproductive Aging and Bone Health Program at Yale Reproductive Endocrinology, specializing in the areas of infertility, reproductive aging and…
Dr. Lubna Pal, MD, is a Director of the Reproductive Aging and Bone Health Program at Yale Reproductive Endocrinology, specializing in the areas of infertility, reproductive aging and…
Dr. Lubna Pal, MD, is a Director of the Reproductive Aging and Bone Health Program at Yale Reproductive Endocrinology, specializing in the areas of infertility, reproductive aging and…